A Phase II, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NS-065/NCNP-01 in Boys with Duchenne Muscular Dystrophy (DMD)

Administered By

Awarded By

Contributors

Start/End

  • March 24, 2017 - October 10, 2019